Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss
Condition(s):Lactation SuppressedLast Updated:February 22, 2024Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Lactation SuppressedLast Updated:February 22, 2024Enrolling by invitation
Condition(s):Lactation SuppressedLast Updated:November 14, 2022Completed
Condition(s):Lactation SuppressedLast Updated:July 31, 2019Unknown status
Condition(s):Lactation SuppressedLast Updated:February 13, 2024Completed
Condition(s):Lactation Suppressed; Second Trimester AbortionLast Updated:March 8, 2024Recruiting
Condition(s):Lactation Suppressed; Cabergoline Adverse Reaction; Postpartum DVT; Postpartum DepressionLast Updated:September 28, 2021Unknown status
Condition(s):Low Milk Supply; Pre-diabetes; Insulin Resistance; Suppressed LactationLast Updated:October 19, 2020Completed
Condition(s):HIV InfectionsLast Updated:September 27, 2012Unknown status
Condition(s):Music; Breastfeeding; Newborn; MotherLast Updated:September 26, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.